Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:43 AM
Ignite Modification Date:
2025-12-25 @ 1:43 AM
NCT ID:
NCT00953394
Eligibility Criteria:
Inclusion Criteria:
* histological diagnosis of well-differentiated neuroendocrine carcinoma according to the World Health Organization (WHO) classification;
* locally advanced or metastatic disease not amenable to surgery with radical intent;
* at least one measurable target lesion;
* radiological documentation of progressive disease;
* ECOG performance status grade \<=2;
* life expectancy \>12 weeks;
* adequate bone marrow reserve;
* adequate hepatic and renal function;
* ability to comply with the protocol procedures (including geographic accessibility);
* written informed consent.
Exclusion Criteria:
* non-malignant systemic disease or conditions that precluded patients from receiving the study therapy;
* second primary malignancies and previous systemic antineoplastic treatment including somatostatin analogues;
* history of prior malignancy, excepted for cured non-melanoma skin cancer, and cured in situ cervical carcinoma.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00953394
Study Brief:
Protocol Section:
NCT00953394